It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Rational Pharmacotherapy in CardiologyStatins and myopathy: molecular mechanisms

Statins and myopathy: molecular mechanisms

O.M. Drapkina*, E.M. Chernova, O.N. Korneeva

I.M. Setchenov First Moscow State Medical University. Trubetskaya ul 8-2, Moscow, 119991, Russia.

The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy, as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application for the prevention of this complication are considered.

Key words: statins, myopathy, coenzyme Q10, rosuvastatin.

Rational Pharmacother. Card. 2012;8(3):

* Corresponding author: drapkina@bk.ru


Download free full text (PDF)

© 2007 — 2014 «Rational Pharmacotherapy in Cardiology»
«Stolichnaya Izdatelskaya Kompaniya»

ISSN 1819-6446(Print) ISSN 2225-3653 (Online)